Clinical Trial Update: Observational Study to Assess a 6-months Treatment With Gladem

View source ↗

Summary

Completed observational study evaluating six months of Gladem treatment for depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Gladem

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Depressive Disorder | Status: COMPLETED